Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
13 pending office actions • 9 art units • 12 examiners • 0 of 13 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days
Cepheid has 12 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 11 examiners and 8 art units, indicating a broad examination footprint with some examiner and art-unit overlap.
YU, TIAN NMN is the busiest examiner, with 2 pending matters. The profile supports centralized docket management, while response preparation should remain tailored to the separate examiner and art-unit assignments.
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 4 (31%) |
| §103 only | 5 (38%) |
| Multi-statute (no §101) | 4 (31%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| YU, TIAN NMN | 2 | 55.6% | +19.3% |
| TSUI, YUNG-SHENG M | 1 | 66.5% | +6.3% |
| GRAY, JESSICA | 1 | 0.0% | +0.0% |
| KOVACH, KARA NICOLE | 1 | 85.7% | +100.0% |
| SETZER, NICHOLAS LEE | 1 | 68.2% | +41.2% |
| KRCHA, MATTHEW D | 1 | 64.3% | +35.5% |
| ABEL, LENORA A | 1 | 68.7% | +33.8% |
| WASHINGTON, BRITNEY NICOLE | 1 | 84.0% | +13.2% |
| LYLE, SOPHIA YUAN | 1 | 57.5% | +56.9% |
| JOHANNSEN, DIANA B | 1 | 53.2% | +42.8% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18309691 | NUCLEIC ACID EXTRACTION AND ISOLATION WITH HEAT LABILE SILANES AND CHEMICALLY MODIFIED SOLID SUPPORTS | WASHINGTON, BRITNEY NICOLE | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18527039 | MOTOR HAVING INTEGRATED ACTUATOR WITH ABSOLUTE ENCODER AND METHODS OF USE | SETZER, NICHOLAS LEE | 23d overdue |
| 17576307 | COMPOSITIONS AND METHODS FOR DISCRIMINATING BACTERIAL AND VIRAL INFECTIONS IN A HUMAN SUBJECT | JOHANNSEN, DIANA B | 1d overdue |
| 18184326 | UNITARY CARTRIDGE BODY AND ASSOCIATED COMPONENTS AND METHODS OF MANUFACTURE | LYLE, SOPHIA YUAN | 26d |
| 18680611 | Methods of Detecting Bladder Cancer | TSUI, YUNG-SHENG M | — |
| 18583105 | USE OF DESTABILIZING NUCLEOTIDE TRIPHOSPHATES TO REDUCE AMPLICON FOLDING AND Tm | GRAY, JESSICA | — |
| 18540460 | MPOX CLADE II BIOMARKER PANEL | KOVACH, KARA NICOLE | — |
| 18460253 | SEAL FAILURE DETECTION SYSTEM AND METHODS | KRCHA, MATTHEW D | — |
| 18460266 | FAULTY UNIT DETECTION SYSTEM AND METHODS | ABEL, LENORA A | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17240865 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | YU, TIAN NMN | 32d overdue |
| 18527039 | MOTOR HAVING INTEGRATED ACTUATOR WITH ABSOLUTE ENCODER AND METHODS OF USE | SETZER, NICHOLAS LEE | 23d overdue |
| 17576307 | COMPOSITIONS AND METHODS FOR DISCRIMINATING BACTERIAL AND VIRAL INFECTIONS IN A HUMAN SUBJECT | JOHANNSEN, DIANA B | 1d overdue |
| 18184326 | UNITARY CARTRIDGE BODY AND ASSOCIATED COMPONENTS AND METHODS OF MANUFACTURE | LYLE, SOPHIA YUAN | 26d |
| 18691007 | ECHO AMPLIFICATION: A COMPREHENSIVE SYSTEM OF CHEMISTRY AND METHODS FOR AMPLIFICATION AND DETECTION OF SPECIFIC NUCLEIC ACID SEQUENCES | YU, TIAN NMN | — |
| 18540460 | MPOX CLADE II BIOMARKER PANEL | KOVACH, KARA NICOLE | — |
| 18460253 | SEAL FAILURE DETECTION SYSTEM AND METHODS | KRCHA, MATTHEW D | — |
| 18460266 | FAULTY UNIT DETECTION SYSTEM AND METHODS | ABEL, LENORA A | — |
| Art Unit | Apps |
|---|---|
| 1681 | 3 |
| 1682 | 2 |
| 1796 | 2 |
| 1684 | 1 |
| 2834 | 1 |
| 1799 | 1 |
| 1797 | 1 |
| 1671 | 1 |
| 1693 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18680611 | Methods of Detecting Bladder Cancer | TSUI, YUNG-SHENG M | 1684 | §101DP | Non-Final OA | — | Pending | May 31, 2024 |
| 18691007 | ECHO AMPLIFICATION: A COMPREHENSIVE SYSTEM OF CHEMISTRY AND METHODS FOR AMPLIFICATION AND DETECTION OF SPECIFIC NUCLEIC ACID SEQUENCES | YU, TIAN NMN | 1681 | §103 | Non-Final OA | — | Pending | Mar 11, 2024 |
| 18583105 | USE OF DESTABILIZING NUCLEOTIDE TRIPHOSPHATES TO REDUCE AMPLICON FOLDING AND Tm | GRAY, JESSICA | 1682 | §103§112 | Non-Final OA | — | Pending | Feb 21, 2024 |
| 18540460 | MPOX CLADE II BIOMARKER PANEL | KOVACH, KARA NICOLE | 1681 | §101§112 | Non-Final OA | — | Pending | Dec 14, 2023 |
| 18527039 | MOTOR HAVING INTEGRATED ACTUATOR WITH ABSOLUTE ENCODER AND METHODS OF USE | SETZER, NICHOLAS LEE | 2834 | §103§112 | Final Rejection | 23d overdue | Pending | Dec 01, 2023 |
| 18460253 | SEAL FAILURE DETECTION SYSTEM AND METHODS | KRCHA, MATTHEW D | 1796 | §103§112 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18460266 | FAULTY UNIT DETECTION SYSTEM AND METHODS | ABEL, LENORA A | 1799 | §101§102§103 | Final Rejection | — | Pending | Sep 01, 2023 |
| 18309691 | NUCLEIC ACID EXTRACTION AND ISOLATION WITH HEAT LABILE SILANES AND CHEMICALLY MODIFIED SOLID SUPPORTS | WASHINGTON, BRITNEY NICOLE | 1797 | §103 | Non-Final OA | — | Pending | Apr 28, 2023 |
| 18184326 | UNITARY CARTRIDGE BODY AND ASSOCIATED COMPONENTS AND METHODS OF MANUFACTURE | LYLE, SOPHIA YUAN | 1796 | §102§103 | Final Rejection | 26d | Pending | Mar 15, 2023 |
| 17576307 | COMPOSITIONS AND METHODS FOR DISCRIMINATING BACTERIAL AND VIRAL INFECTIONS IN A HUMAN SUBJECT | JOHANNSEN, DIANA B | 1682 | §101§112 | Non-Final OA | 1d overdue | Pending | Jan 14, 2022 |
| 17358523 | METHODS OF DETECTING SARS-COV-2, INFLUENZA, AND RSV | ALLEN, MICHAEL D | 1671 | §103 | Final Rejection | — | Pending | Jun 25, 2021 |
| 17240865 | EXPONENTIAL BASE-3 AND GREATER NUCLEIC ACID AMPLIFICATION WITH CYCLING PROBE | YU, TIAN NMN | 1681 | §103 | Non-Final OA | 32d overdue | Pending | Apr 26, 2021 |
| 17269198 | NUCLEIC ACID ISOLATION AND RELATED METHODS | LEE, HOI YAN NMN | 1693 | §103 | Non-Final OA | — | Pending | Feb 17, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialCepheid has 13 pending office actions as of October 2026, spread across 9 art units and 12 examiners.
Tian Nmn Yu has the most, with 2 of Cepheid's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
